Press Room

Doz

JACKSON, Miss. –  Cancer advocates are celebrating after Gov.

Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of ‘Delaware Advocacy Day.’ The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer’s Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans’ access to biomarker testing.

The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.  

JACKSON, Miss. –  The Mississippi Senate passed “Jill’s Law” House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated he

JACKSON, Miss. – The Mississippi Senate passed Senate Bill 2694 Wednesday, February 11, paving the way for increased access to biomarker testing for patients across the Magnolia State.

Más de una docena de voluntarios de ACS CAN se reunieron en el Capitolio de Nueva York para instar a los legisladores a que preserven el acceso a las pruebas de biomarcadores, una prioridad para más de 100 organizaciones.

JACKSON, Miss. – Dozens of cancer patients, survivors, caregivers and advocates will come from across Mississippi to the State Capitol on Wednesday, February 4 for the American Cancer Society Cancer Action Network’s (ACS CAN) annual

NASHVILLE, Tenn.

JACKSON, Miss. –  The Mississippi House passed House Bill 565 Wednesday, paving the way for increased access to biomarker testing for patients across the Magnolia State.